Study: NCT03164057

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine solution is administered intravenously (IV) over a period of 10-40 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine
Description: Administered intravenously (IV) over approximately one hour.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV or intrathecally (IT).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: ITMHA
Description: Given IT.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV over approximately 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: Given IV or intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Given PO.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Given IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Given IV immediately before idarubicin administration.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stem Cell Transplant
Description: The transplant protocol will depend on the patient's donor and transplant physician's preference.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stem Cell Transplant
Description: The transplant protocol will depend on the patient's donor and transplant physician's preference.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stem Cell Transplant
Description: The transplant protocol will depend on the patient's donor and transplant physician's preference.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stem Cell Transplant
Description: The transplant protocol will depend on the patient's donor and transplant physician's preference.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn
Description: May be used in the event of an Erwinia asparaginase shortage. Given intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn
Description: May be used in the event of an Erwinia asparaginase shortage. Given intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn
Description: May be used in the event of an Erwinia asparaginase shortage. Given intramuscularly (IM).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn
Description: May be used in the event of an Erwinia asparaginase shortage. Given intramuscularly (IM).